Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fujifilm silvamp tb-lam for the diagnosis of tuberculosis in nigerian adults

  • Comella-del-Barrio, Patricia|||0000-0002-2433-9864
  • Bimba, John|||0000-0001-7847-4271
  • Adelakun, Ramota
  • Kontogianni, Konstantina
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Osazuwa, Okoedoh
  • Creswell, Jacob|||0000-0002-4885-940X
  • Cuevas, Luis E.|||0000-0002-6581-0587
  • Domínguez, José|||0000-0001-7888-0309
There is a need for diagnostics for tuberculosis (TB) that are easy to use, able to screen non-sputum samples, and able to provide rapid results for the management of both immunocompromised and immunocompetent individuals. The Fujifilm SILVAMP TB LAM (FujiLAM) assay, a new non-sputum based point of need test for the diagnosis of TB, could potentially address most of these needs. We evaluated the performance of FujiLAM in HIV positive and HIV negative patients with presumptive TB attending three district hospitals in Nigeria. Consecutive patients were asked to provide urine samples on the spot, which were tested with FujiLAM. The results were compared against a positive culture and/or Xpert MTB/RIF as the reference standard. Forty-five patients had bacteriologically confirmed TB, and 159 had negative culture and Xpert MTB/RIF (no TB). The FujiLAM test was positive in 23 (sensitivity 65.7%, 95% CI = 48-80) HIV negative and seven (70%, 95% CI = 35-92) HIV positive patients with bacteriological confirmation of TB. FujiLAM was negative in 97 (specificity 99.0%, 95% CI = 94-100) HIV negative and 56 (93.3%, 95% CI = 83-98) HIV positive patients without TB. The FujiLAM test has good diagnostic accuracy for considering its application in both HIV positive and HIV negative patients with TB.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Diagnostic Performance of the Fujifilm SILVAMP TB-LAM in Children with Presumptive Tuberculosis

  • Comella-del-Barrio, Patricia|||0000-0002-2433-9864
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Gautier, Jacqueline
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Doresca, Mariette Jean Coute
  • Sallés-Mingels, Beatriz
  • Canales-Aliaga, Lydia
  • Narcisse, Margareth
  • Pérez-Porcuna, Tomás M.|||0000-0002-9951-7768
  • Creswell, Jacob|||0000-0002-4885-940X
  • Cuevas, Luis E.|||0000-0002-6581-0587
  • Domínguez, José|||0000-0001-7888-0309
Current diagnostics for tuberculosis (TB) only manage to confirm a small proportion of children with TB and require respiratory samples, which are difficult to obtain. There is a need for non-invasive biomarker-based tests as an alternative to sputum testing. Fujifilm SILVAMP TB lipoarabinomannan (FujiLAM), a lateral-flow test to detect lipoarabinomannan in urine, is a novel non-sputum-based point-of-care diagnostic reported to have increased sensitivity for the diagnosis of TB among human immunodeficiency virus (HIV)-infected adults. We evaluate the performance of FujiLAM in children with presumptive TB. Fifty-nine children attending a paediatric hospital in Haiti with compatible signs and symptoms of TB were examined using Xpert MTB/RIF, smear microscopy and X-rays, and classified according to the certainty of diagnosis into bacteriologically confirmed TB (n = 5), unconfirmed TB (bacteriologically negative, n = 50) and unlikely TB (n = 4). Healthy children (n = 20) were enrolled as controls. FujiLAM sensitivity and specificity were 60% and 95% among children with confirmed TB. FujiLAM's high specificity and its characteristics as a point-of-care indicate the test has a good potential for the diagnosis of TB in children.